uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Is pathologic complete response (pCR) a valid marker of outcome even in large breast cancer?: Clinical results from a neoadjuvant trial using a combination of epirubicin, docetaxel and bevacizumab (PROMIX)
Show others and affiliations
2015 (English)In: Cancer Research, ISSN 0008-5472, E-ISSN 1538-7445, Vol. 75, no 9, P3-11-14Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2015. Vol. 75, no 9, P3-11-14
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-259213ISI: 000356730202108OAI: oai:DiVA.org:uu-259213DiVA: diva2:843706
Conference
37th Annual CTRC-AACR San Antonio Breast Cancer Symposium, DEC 09-13, 2014, San Antonio, TX
Available from: 2015-07-30 Created: 2015-07-29 Last updated: 2017-12-04Bibliographically approved

Open Access in DiVA

No full text

Authority records BETA

Lindman, Henrik

Search in DiVA

By author/editor
Lindman, Henrik
By organisation
Experimental and Clinical Oncology
In the same journal
Cancer Research
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 328 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf